Enfusion, Inc.

ENFN · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$4$9-$13-$282
Dep. & Amort.$12$10$6$4
Deferred Tax$0$0$0$3
Stock-Based Comp.$19$7$25$290
Change in WC$0-$9-$6-$15
Other Non-Cash-$0$8$2$0
Operating Cash Flow$35$26$14-$0
Investing Activities
PP&E Inv.-$4-$4-$8-$8
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$10-$5-$4-$2
Investing Cash Flow-$14-$10-$8-$8
Financing Activities
Debt Repay.$0$0$0-$100
Stock Issued$0$17$0$261
Stock Repurch.$0$0-$8-$88
Dividends Paid$0$0$0-$3
Other Fin. Act.-$1-$60-$8-$11
Financing Cash Flow-$1-$43-$8$59
Forex Effect-$1$0-$0-$0
Net Chg. in Cash$19-$27-$2$50
Supplemental Information
Beg. Cash$36$63$64$14
End Cash$54$36$63$64
Free Cash Flow$31$16$6-$8
Enfusion, Inc. (ENFN) Financial Statements & Key Stats | AlphaPilot